Equity Research, Broker Reports, and media content on Roche Holding Ltd Dividend Right Cert.

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Roche Holding Ltd Dividend Right Cert.
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Roche Holding Ltd Dividend Right Cert.

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Roche Holding Ltd Dividend Right Cert.. We currently have 73 research reports from 6 professional analysts.

Date Source Announcement
10Dec18 06:03 GNW New member proposed for election to Roche Board of Directors
10Dec18 06:00 GNW Changes to the Roche Corporate Executive Committee
07Dec18 06:00 GNW FDA approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer
05Dec18 13:15 GNW Roche's Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
05Dec18 06:00 GNW FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer
04Dec18 06:00 GNW New Venclexta/Venclyxto data demonstrate deep responses in two of the most common types of leukaemia
03Dec18 18:30 GNW Roche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children with haemophilia A with factor VIII inhibitors
  • Frequency of research reports

     

  • Research reports on

    Roche Holding Ltd Dividend Right Cert.

  • Providers covering

    Roche Holding Ltd Dividend Right Cert.